1 Min Read
Aug 23 (Reuters) - Sms Pharmaceuticals Ltd:
* PMDA (Japan) inspection at manufacturing facility - unit-II, located at Bachupally, Hyderabad concluded with no critical observations Source text: (bit.ly/2wmyq8n) Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.